Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment

被引：1
作者：
Katsiki, Niki [1 ]
Athyros, Vasilios G. [2 ]
机构：
[1] AHEPA Univ Hosp, Dept Internal Med 1, Ctr Diabet Endocrinol & Metab, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Hippocrat Hosp, Med Sch, Propedeut Dept Internal Med 2, Thessaloniki, Greece
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2019年 / 35卷 / 07期
关键词：
FATTY LIVER-DISEASE; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR OUTCOMES; STATINS; RISK; BILIRUBIN; LIRAGLUTIDE;
D O I：
10.1080/03007995.2019.1589152
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1305 / 1306
页数：2
相关论文
共 50 条
[21]   Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus [J].
Li, Wei-Dong ;
Fu, Kun-Fa ;
Li, Gui-Mei ;
Lian, Yan-Shu ;
Ren, Ai-Min ;
Chen, Yun-Jue ;
Xia, Jin-Rong .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) :9607-9613
[22]   Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes [J].
Lembo, Erminia ;
Russo, Maria Francesca ;
Verrastro, Ornella ;
Anello, Danila ;
Angelini, Giulia ;
Iaconelli, Amerigo ;
Guidone, Caterina ;
Stefanizzi, Gianluigi ;
Ciccoritti, Luigi ;
Greco, Francesco ;
Sessa, Luca ;
Riccardi, Laura ;
Pompili, Maurizio ;
Raffaelli, Marco ;
Vecchio, Fabio Maria ;
Bornstein, Stefan R. ;
Mingrone, Geltrude ;
Gastaldelli, Amalia ;
Capristo, Esmeralda .
DIABETES & METABOLISM, 2022, 48 (05)
[23]   Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? [J].
Mazzotti, Arianna ;
Caletti, Maria Turchese ;
Marchignoli, Francesca ;
Forlani, Giulia ;
Marchesini, Giulio .
DIGESTIVE AND LIVER DISEASE, 2017, 49 (03) :235-240
[24]   Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment [J].
Zhu, Bo ;
Chan, Siu-Lung ;
Li, Jack ;
Li, Kathryn ;
Wu, Hao ;
Cui, Kui ;
Chen, Hong .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[25]   Future trends in the treatment of non-alcoholic steatohepatitis [J].
Fiorucci, Stefano ;
Biagioli, Michele ;
Distrutti, Eleonora .
PHARMACOLOGICAL RESEARCH, 2018, 134 :289-298
[26]   Nitrosamine Exposure Causes Insulin Resistance Diseases: Relevance to Type 2 Diabetes Mellitus, Non-Alcoholic Steatohepatitis, and Alzheimer's Disease [J].
Tong, Ming ;
Neusner, Alexander ;
Longato, Lisa ;
Lawton, Margot ;
Wands, Jack R. ;
de la Monte, Suzanne M. .
JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (04) :827-844
[27]   Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma [J].
Weinmann, Arndt ;
Alt, Yvonne ;
Koch, Sandra ;
Nelles, Carina ;
Dueber, Christoph ;
Lang, Hauke ;
Otto, Gerd ;
Zimmermann, Tim ;
Marquardt, Jens U. ;
Galle, Peter R. ;
Woerns, Marcus A. ;
Schattenberg, Joern M. .
BMC CANCER, 2015, 15
[28]   Characteristics of contemporary drug clinical trials regarding the treatment of non-alcoholic steatohepatitis [J].
Zhao, Shanshan ;
Zhang, Lan ;
Zhao, Junzhe ;
Kota, Vishnu Goutham ;
Venkat, Kartik Mitra ;
Tasnim, Farah ;
Yu, Hanry .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
[29]   Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugs [J].
Katsiki, Niki ;
Athyros, Vasilios G. ;
Mikhailidis, Dimitri P. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) :521-522
[30]   Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis [J].
Leite, Nathalie Carvalho ;
Salles, Gil Fernando ;
Lopes Cardoso, Claudia Regina ;
Villela-Nogueira, Cristiane Alves .
HEPATOLOGY RESEARCH, 2013, 43 (05) :508-515
12345